Effects of tyrosine kinase inhibitor therapy on skin toxicity and skin-related quality of life in patients with lung cancer: An observational study

Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy is the primary treatment option for patients with non-small cell lung cancer (NSCLC). However, one of the major adverse effects associated with this therapy is skin toxicity, which impacts the patient's quality of lif...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Li-Chuan, Chen, Kang-Hua, Wang, Chih-Liang, Weng, Li-Chueh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306373/
https://www.ncbi.nlm.nih.gov/pubmed/32501998
http://dx.doi.org/10.1097/MD.0000000000020510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306373/
https://www.ncbi.nlm.nih.gov/pubmed/32501998
http://dx.doi.org/10.1097/MD.0000000000020510

Ejemplares similares